Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

November 1, 1994; Volume 35,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Altmann, Annette

    1. You have access
      Fluorodeoxyglucose Uptake In Vitro: Aspects of Method and Effects of Treatment with Gemcitabine
      Uwe Haberkorn, Iris Morr, Franz Oberdorfer, Matthias E. Bellemann, Johannes Blatter, Annette Altmann, Barbara Kahn and Gerhard van Kaick
      Journal of Nuclear Medicine November 1, 1994, 35 (11) 1842-1850;
  2. Anderson, Jon R.

    1. You have access
      Display of Merged Multimodality Brain Images Using Interleaved Pixels with Independent Color Scales
      Kelly Rehm, Stephen C. Strother, Jon R. Anderson, Kirt A. Schaper and David A. Rottenberg
      Journal of Nuclear Medicine November 1, 1994, 35 (11) 1815-1821;
  3. Anner, Haim

    1. You have access
      Transient Neurological Events During Dipyridamole Stress Test: An Arterial Steal Phenomenon?
      David Schechter, Moshe Bocher, Yacov Berlatzky, Haim Anner, Zohar Argov, Gideon Beer, Yodphat Krausz, Mervyn S. Gotsman and Roland Chisin
      Journal of Nuclear Medicine November 1, 1994, 35 (11) 1802-1804;
  4. Argov, Zohar

    1. You have access
      Transient Neurological Events During Dipyridamole Stress Test: An Arterial Steal Phenomenon?
      David Schechter, Moshe Bocher, Yacov Berlatzky, Haim Anner, Zohar Argov, Gideon Beer, Yodphat Krausz, Mervyn S. Gotsman and Roland Chisin
      Journal of Nuclear Medicine November 1, 1994, 35 (11) 1802-1804;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 35, Issue 11
November 1, 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire